Tiba Aynechi is Director at MBX Biosciences, Inc. (MBX). They have made 1 open-market trade across 1 company since 2024, most recently 2024-09-16.
CIK 0001669220
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12.0M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MBX | 1,386,335 | $68.8M |
Shares reported on the most recent Form 4, priced at the 2024-09-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBX | BUY | 2024-09-16 | 2024-09-17 | $16.00 | $12.0M | +11.4% | +7.7% | -11.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.